CEA is a broad‐spectrum tumor marker that is combined with other biomarkers to diagnose primary HCC.24 However, we found that CEA was significantly elevated in MHC, which is helpful for differential diagnosis between primary and metastatic HCC. This evidence concerns the gene CEACAM5 and neoplasm.